Literature DB >> 15903351

Predicting and preventing adverse drug reactions in the very old.

Louis Merle1, Marie-Laure Laroche, Thierry Dantoine, Jean-Pierre Charmes.   

Abstract

The size of the elderly population has been increasing steadily for several years. Individuals in this age group often have several concomitant diseases that require treatment with multiple medications. These drugs, for various reasons and especially as a consequence of potential accumulation, may be associated with adverse reactions. Of the numerous factors that can favour the occurrence of these adverse drug reactions, the most important are the pathophysiological consequences of aging, particularly as these apply to the very old. Although absorption of drugs is not usually reduced in the elderly, diffusion, distribution and particularly elimination decline with age. Furthermore, while hepatic metabolic function is fairly normal, renal function is usually markedly depressed in very old individuals, and this can translate into clinical consequences if it is not taken into account. This is why, before administration of any drug in the elderly, evaluation of glomerular filtration rate is essential. Validated estimations such as those obtained from the classical Cockcroft-Gault formula or from more recent methodologies are required. In addition to reductions in various organ functions, factors connected with very old age such as frailty, falls, abnormal sensitivity to medications and polypathology, all of which tend to be more common in the last years of life, all directly impact on adverse drug reaction occurrence. Given these characteristics of the elderly population, the best way to reduce the prevalence of adverse drug reactions in this group is to limit drug prescription to essential medications, make sure that use of prescribed agents is clearly explained to the patient, give drugs for as short a period as possible, and periodically re-evaluate all use of drugs in the elderly.

Entities:  

Mesh:

Year:  2005        PMID: 15903351     DOI: 10.2165/00002512-200522050-00003

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  81 in total

Review 1.  Supercentenarians: slower ageing individuals or senile elderly?

Authors:  J Robine; J W Vaupel
Journal:  Exp Gerontol       Date:  2001-04       Impact factor: 4.032

2.  [Pharmacokinetic changes during renal failure and in the elderly].

Authors:  T Dantoine; J P Charmes; L Merle
Journal:  Presse Med       Date:  2001-10-13       Impact factor: 1.228

Review 3.  Clinical practice. Preventing falls in elderly persons.

Authors:  Mary E Tinetti
Journal:  N Engl J Med       Date:  2003-01-02       Impact factor: 91.245

4.  The effect of age on glucuronidation and sulphation of paracetamol by human liver fractions.

Authors:  B Herd; H Wynne; P Wright; O James; K Woodhouse
Journal:  Br J Clin Pharmacol       Date:  1991-12       Impact factor: 4.335

5.  The aging liver. Drug clearance and an oxygen diffusion barrier hypothesis.

Authors:  D G Le Couteur; A J McLean
Journal:  Clin Pharmacokinet       Date:  1998-05       Impact factor: 6.447

6.  Age-related changes in cerebrospinal fluid protein concentrations.

Authors:  M J Garton; G Keir; M V Lakshmi; E J Thompson
Journal:  J Neurol Sci       Date:  1991-07       Impact factor: 3.181

Review 7.  Drug transfer across the blood-brain barrier and improvement of brain delivery.

Authors:  P Jolliet-Riant; J P Tillement
Journal:  Fundam Clin Pharmacol       Date:  1999       Impact factor: 2.748

8.  The post-fall syndrome. A study of 36 elderly patients.

Authors:  J Murphy; B Isaacs
Journal:  Gerontology       Date:  1982       Impact factor: 5.140

Review 9.  Drug treatment as a cause of falls in old age. A review of the offending agents.

Authors:  A J Campbell
Journal:  Drugs Aging       Date:  1991 Jul-Aug       Impact factor: 3.923

Review 10.  Cyclosporin pharmacokinetics in the elderly.

Authors:  J M Kovarik; E U Koelle
Journal:  Drugs Aging       Date:  1999-09       Impact factor: 4.271

View more
  40 in total

Review 1.  Underprescription of beneficial medicines in older people: causes, consequences and prevention.

Authors:  Antonio Cherubini; Andrea Corsonello; Fabrizia Lattanzio
Journal:  Drugs Aging       Date:  2012-06-01       Impact factor: 3.923

Review 2.  Adverse drug reactions in older people: detection and prevention.

Authors:  Mirko Petrovic; Tischa van der Cammen; Graziano Onder
Journal:  Drugs Aging       Date:  2012-06-01       Impact factor: 3.923

Review 3.  Practical considerations for the treatment of elderly patients with migraine.

Authors:  Paola Sarchielli; Maria Luisa Mancini; Paolo Calabresi
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

4.  Reduction in targeted potentially inappropriate medication use in elderly inpatients: a pragmatic randomized controlled trial.

Authors:  Benoit Cossette; Jean-François Éthier; Thomas Joly-Mischlich; Josée Bergeron; Geneviève Ricard; Serge Brazeau; Mathieu Caron; Olivier Germain; Hélène Payette; Janusz Kaczorowski; Mitchell Levine
Journal:  Eur J Clin Pharmacol       Date:  2017-07-17       Impact factor: 2.953

5.  Impact of hospitalisation in an acute medical geriatric unit on potentially inappropriate medication use.

Authors:  Marie-Laure Laroche; Jean-Pierre Charmes; Yves Nouaille; Annie Fourrier; Louis Merle
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

6.  Inappropriate medication use and prescribing indicators in elderly Australians: development of a prescribing indicators tool.

Authors:  Benjamin J Basger; Timothy F Chen; Rebekah J Moles
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 7.  Explicit criteria for potentially inappropriate medications to reduce the risk of adverse drug reactions in elderly people: from Beers to STOPP/START criteria.

Authors:  Andrea Corsonello; Graziano Onder; Angela Marie Abbatecola; Enrico Eugenio Guffanti; Piero Gareri; Fabrizia Lattanzio
Journal:  Drug Saf       Date:  2012-01       Impact factor: 5.606

8.  Association Between Anticholinergic Drug Use and Health-Related Quality of Life in Community-Dwelling Older Adults.

Authors:  Benoit Cossette; Maimouna Bagna; Modou Sene; Caroline Sirois; Gabrielle P Lefebvre; Olivier Germain; José A Morais; Pierrette Gaudreau; Hélène Payette
Journal:  Drugs Aging       Date:  2017-10       Impact factor: 3.923

9.  Prevalence and factors associated with polypharmacy in older people with cancer.

Authors:  Justin P Turner; Sepehr Shakib; Nimit Singhal; Jonathon Hogan-Doran; Robert Prowse; Sally Johns; J Simon Bell
Journal:  Support Care Cancer       Date:  2014-03-02       Impact factor: 3.603

10.  Identifying and preventing adverse drug events in elderly hospitalised patients: a randomised trial of a program to reduce adverse drug effects.

Authors:  C Trivalle; T Cartier; C Verny; A-M Mathieu; P Davrinche; H Agostini; L Becquemont; P Demolis
Journal:  J Nutr Health Aging       Date:  2010-01       Impact factor: 4.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.